Læknaneminn - 01.04.1995, Blaðsíða 23

m-Úíimhúdvs'mYós á fyrstu
stigum as tm am e ð í erðar:
1.
Koma í veg fyrir óafturkræfar og skaðlegar
breytingar í lungum (1, 2, 4)
2.
Fækka innlögnum á sjúkrahús (1, 3)
3.
Minnka þörffyrir berkjuvíkkancli lyf (1, 2)
4.
Sparafjármuni, því heildarkostnaður við
umönnun sjúklinga minnkar (3)
Berkjuslímhúð sjúklings með nýgreindan mildan astma,
jyrir og eftir 3ja mánaða meðferð með búdesóníð (5)
ASTKA
ÆKKKKM Astra Island ■■■■k
!• Agertoft L, and Pedersen S. Effects of long term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children.
Respiratory Medicine. 1994; 88:373-381.
2. Haahtela T, et al. Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma.
New EngJ Med. 1994; 331: 700-705
3. Boman G, Gerdtham U, Hertzman P, Jönsson B. Impact of inhaled corticosteroids on asthma hospitalisation in Sweden. Allergy Clin Immunol
New s 1994; 6 (suppl 2): 150
4. Selroos O, et al. When to start treatment of asthma with inhaled corticosteroid. Eur Resp J. 1994;7 (Suppl 18): 151.
5. Laitinen LA, Laitinen A, Haahtela T. A comparative study of the effects of an inhaled corticosteroid, budesonide and a j32 - agonist, terbutaline, on
airway inflammation in newly diagnosed asthma: a randomized double-blind, parallel-group controlled trial. J Allergy Clin Immunol 1992; 90: 32-42.